Korea United Pharm Inc. (KRX: 033270)

Market Cap	263.48B
Revenue (ttm)	161.44B
Net Income (ttm)	20.02B
Shares Out	14.71M
EPS (ttm)	1,260.76
PE Ratio	14.21
Forward PE	n/a
Dividend	420.00 (2.28%)
Ex-Dividend Date	Dec 27, 2024

Volume	14,816
Open	18,600
Previous Close	18,600
Day's Range	18,430 - 18,760
52-Week Range	17,250 - 28,900
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About Korea United Pharm

Korea United Pharm Inc. engages in the manufacture and sale of pharmaceutical products in South Korea. It offers products in the areas of respiratory system, musculo-skeletal system, gastro-intestinal tract system, cardiovascular system, anti-cancer, anti-infectives, allergy, immune system, central nervous system, and other diseases, as well OTC drugs. The company also exports its products to approximately 40 countries. Korea United Pharm Inc. was founded in 1987 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 665
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 033270

Financial Performance

In 2014, Korea United Pharm's revenue was 155.19 billion, an increase of 13.37% compared to the previous year's 136.89 billion. Earnings were 18.37 billion, an increase of 50.46%.